Novel Small Proteins & Single Domain Antibodies As Therapeutics
Keynote
Speaker：
Neil Goldstein, Ph.D. from SkunkWorx
Sept 11, 2024
1PM CT / 2PM ET
Key Learnings:
1.Using high diversity randomized display libraries to identify novel
agonists and antagonists for both known and “undruggable’ disease-related
targets
2.Developing novel small protein-drug conjugates for
treating cancer and other diseases
3.Developing novel single
domain antibodies for treating cancer and other diseases
Sino
Biological specializes in antibody development and recombinant protein production. All of
Sino
Biological’s products are developed and produced in-house. Sino Biological also offers
pharmaceutical
companies and biotechnology firms a variety of recombinant production and assay services for
pre-clinical
research development.
